High doses dont necessarily speed up healing and may waste product or desensitize receptors over time
Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
We offer several delivery methods to suit your comfort and treatment objectives
Mechanistic and preclinical data suggest reduced fibrosis, improved closure quality, and balanced remodelling References References Regenerative & protective actions, gene-level mechanisms (review) Copper peptides in skin anti-aging/cosmetics (review) PubMed record of GHK-Cu review Narrative reviewmusculoskeletal healing, angiogenesis, anti-inflammatory actions Orthopedic sports medicine overview (preclinical + early clinical signal) BPC-157 Functional/therapeutic overview of T4 TB-500 in repair/regeneration (review) Landmark Nature paper TB-500cardiac cell migration/survival & repair Synonyms: Bpc-157, 137525-51-0, Bepecin, Bpc 15 TB500, 885340-08-9, UNII-QHK6Z47GTG, QHK6Z47GTG GHK-Cu acetate, 300801-03-0, TB-500, copper;acetic acid, 2-6-amino-2-[[(2S)-2-(2-aminoacetyl)azanidyl-3-(1H-imidazol-4-yl)propanoyl]amino]hexanoate, GHK-Cu acetate, Gly-is-Lys-Cu(II)